6.1 Development of longitudinal, plaque-targeted imaging platforms Building on emerging MRI-detectable GLP-1RA nanoparticle technologies ( 6.2 Defining GLP-1RA-specific cellular mechanisms Key mechanistic questions remain unresolved, including how GLP-1RAs modulate monocyte-to-macrophage differentiation, macrophage polarization (M1M2), foam-cell formation, and cholesterol efflux within atherosclerotic lesions
Eur J Clin Nutr 58:391402 Broome CS, McArdle F, Kyle JA, et al
Ongoing Research on Combination Therapies Empagliflozin's role in combination therapies continues to be a significant area of research
This NRF2 dysregulation has been strongly linked to deficits in memory and executive function, indicating its potential role in the cognitive decline observed in these patients (Zhou et al
Glutathione can help lighten the skin, but it takes work to maintain the results
Industry giants like Pfizer, Novo Nordisk, and Eli Lilly dominate, offering a broad portfolio that includes GLP-1 receptor agonists and other advanced therapeutics
